Literature DB >> 25172243

Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies.

Jia Pei Lim1, Jérôme Devaux2, Nobuhiro Yuki3.   

Abstract

Guillain-Barré syndrome is classified into acute inflammatory demyelinating polyneuropathy and acute motor axonal neuropathy. Whereas autoantibodies to GM1 or GD1a induce the development of acute motor axonal neuropathy, pathogenic autoantibodies have yet to be identified in acute inflammatory demyelinating polyneuropathy and chronic inflammatory demyelinating polyneuropathy. This review highlights the importance of autoantibodies to peripheral nerve proteins in the physiopathology of acute and chronic inflammatory demyelinating polyneuropathies. Moreover, we listed up other potential antigens, which may become helpful biomarkers for acquired, dysimmune demyelinating neuropathies based on their critical functions during myelination and their implications in hereditary demyelinating neuropathies.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute inflammatory demyelinating polyneuropathy; Autoantibody; Charcot–Marie–Tooth disease; Chronic inflammatory demyelinating polyneuropathy; Experimental autoimmune neuritis; Guillain–Barré syndrome

Mesh:

Substances:

Year:  2014        PMID: 25172243     DOI: 10.1016/j.autrev.2014.08.005

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  10 in total

Review 1.  Progress in inflammatory neuropathy -the legacy of Dr Jack Griffin.

Authors:  Eva L Feldman; Richard A C Hughes; Hugh J Willison
Journal:  Nat Rev Neurol       Date:  2015-10-13       Impact factor: 42.937

Review 2.  Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications.

Authors:  Luis Querol; Jérôme Devaux; Ricard Rojas-Garcia; Isabel Illa
Journal:  Nat Rev Neurol       Date:  2017-07-14       Impact factor: 42.937

Review 3.  Immune-mediated neuropathies.

Authors:  Bernd C Kieseier; Emily K Mathey; Claudia Sommer; Hans-Peter Hartung
Journal:  Nat Rev Dis Primers       Date:  2018-10-11       Impact factor: 52.329

4.  The Pathogenesis of the Demyelinating Form of Guillain-Barre Syndrome (GBS): Proteo-peptidomic and Immunological Profiling of Physiological Fluids.

Authors:  Rustam H Ziganshin; Olga M Ivanova; Yakov A Lomakin; Alexey A Belogurov; Sergey I Kovalchuk; Igor V Azarkin; Georgij P Arapidi; Nikolay A Anikanov; Victoria O Shender; Mikhail A Piradov; Natalia A Suponeva; Anna A Vorobyeva; Alexander G Gabibov; Vadim T Ivanov; Vadim M Govorun
Journal:  Mol Cell Proteomics       Date:  2016-05-03       Impact factor: 5.911

Review 5.  Guillain-Barré syndrome in Colombia: where do we stand now?

Authors:  María P Mahecha; Ernesto Ojeda; Daniel A Vega; Juan C Sarmiento-Monroy; Juan-Manuel Anaya
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

6.  Anti-cytokine autoantibodies in postherpetic neuralgia.

Authors:  Ahmad Bayat; Peter D Burbelo; Sarah K Browne; Mark Quinlivan; Bianca Martinez; Steven M Holland; Asokumar Buvanendran; Jeffrey S Kroin; Andrew J Mannes; Judith Breuer; Jeffrey I Cohen; Michael J Iadarola
Journal:  J Transl Med       Date:  2015-10-20       Impact factor: 5.531

7.  Diagnostic Utility of Auto Antibodies in Inflammatory Nerve Disorders.

Authors:  Delmont Emilien; Willison Hugh
Journal:  J Neuromuscul Dis       Date:  2015-06-04

Review 8.  Comprehensive approaches for diagnosis, monitoring and treatment of chronic inflammatory demyelinating polyneuropathy.

Authors:  Anna Lena Fisse; Jeremias Motte; Thomas Grüter; Melissa Sgodzai; Kalliopi Pitarokoili; Ralf Gold
Journal:  Neurol Res Pract       Date:  2020-12-08

Review 9.  Neuroinflammation in the peripheral nerve: Cause, modulator, or bystander in peripheral neuropathies?

Authors:  Rudolf Martini; Hugh Willison
Journal:  Glia       Date:  2015-08-06       Impact factor: 7.452

10.  Pediatric CIDP: Diagnosis and Management. A Single-Center Experience.

Authors:  Małgorzata Łukawska; Anna Potulska-Chromik; Marta Lipowska; Dorota Hoffman-Zacharska; Beata Olchowik; Magdalena Figlerowicz; Karolina Kanabus; Edyta Rosiak; Anna Kostera-Pruszczyk
Journal:  Front Neurol       Date:  2021-07-02       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.